Ad
related to: merck pharmaceuticals
Search results
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 11 hours agoMerck’s venture arm was an investor in EyeBio. EyeBio’s lead drug, Restoret, is in development to...
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 10 hours agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a pipeline of vision ...
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 9 hours agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 14 hours agoThe latest development comes after Merck announced an investment of more than €300m ($320.8m) in a...
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 11 hours agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 7 hours agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...
Benzinga· 13 hours agoMerck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...
Merck to Acquire EyeBio
Morningstar· 11 hours agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, and Eyebiotech Limited (EyeBio), a privately held ophthalmology-focused biotechnology company, today ...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 4 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Merck nears $1.3 bln takeover of Eyebiotech- WSJ
Investing.com via Yahoo Finance· 1 day agoInvesting.com-- Merck&Company Inc (NYSE:MRK) is close to entering a $1.3 billion deal to buy Eyebiotech, granting the pharmaceutical giant entry into the ...
